New challenges in HIV research
Forty years after its discovery, HIV/AIDS has become a chronic disease thanks to triple therapy. But it still resists being cured and the vaccine is still awaited...
Monsef Benkirane, virologist at the Institute of Human Genetics, takes stock of the new research challenges.
Axel Kahn "being human"
In tribute to Axel Kahn who passed away on 6 July 2021, the IGH looks back on a rich day during which Axel Kahn honoured us with his presence.
On April 15, 2016 Axel Kahn spoke at the Genopolys amphitheatre as part of the Citizens' Days. The conference inaugurated the EUREKA cycle, with a reflection on the human being, this animal endowed with reason.
Open Group Leader Position
The Institute of Human Genetics of Montpellier (IGH) opens a call for applications to a Principal Investigator position in its main areas of interest, namely Genome Dynamics, Genomics, RNA Biology, Computational Biology and AI, Epigenetics, Immunogenetics, Developmental Biology, Cancer and Infectious Diseases.
New research will take place into an aggressive brain tumour
New research will take place into the rare disease after charity Worldwide Cancer Research donated almost £200,000 to a French doctor's project.
The research is led by Dr Domenico Maiorano to better understand how a gene in DNA allows brain cancer cells to survive and grow.
Genome Surveillance and Stability
The Montpellier start-up working on a future treatment against glaucoma awarded by the Cercle Mozart
The Cercle Mozart presented its medical start-up prize yesterday to the Montpellier biotech company MT-Act. On this occasion, the start-up created in 2019 received a check for € 20,000 and will benefit from the support of the association for three years to develop its network.
Nature publication by the LifeTime Initiative: Improving Healthcare and Healthcare Systems in Europe Through "Interceptive" Cellular Medicine
The LifeTime initiative, in which the Institute of Human Genetics (IGH), the CNRS and the Institut Curie participate, brings together hundreds of researchers, clinicians, industry leaders and policy makers both in France and in Europe. Together, they publish their LifeTime Strategic Research Agenda as well as an article in Nature on September 7, 2020, providing their vision and a roadmap for the coming decade.
Contact IGH Giacomo CAVALLI
IGH's scientific response to COVID-19
During the developing COVID-19 pandemic the Institute of Human Genetics and its researchers are playing their part in tackling the virus.
L'Institut de Génétique Humaine fête ses 20 ans
Pour célébrer cet anniversaire, l'IGH, en partenariat avec la nouvelle Faculté de Médecine de Montpellier, accueille un panel prestigieux de scientifiques internationaux pour une série de conférences.
Résultats du premier appel à projet recherche de l'I-Site MUSE
This Wednesday, December 20, 2017, the MUSE board met to define and announce the final list of winning projects to the call for Research Support projects. 58 projects were selected out of 260 applications submitted, including the one led by William Richie from the Artificial Intelligence and Gene Regulation team at L'IGH.
Contact IGH William RITCHIE
Machine learning and gene regulation
Anémie de Fanconi: une connexion inattendue avec la machinerie d'épissage des ARNs
María Moriel-Carretero, Sara Ovejero et Angelos Constantinou révèlent une connexion inattendue entre des protéines de l'AF et la machinerie de l'épissage des ARNs. Cette étude publiée le 13 octobre 2017 dans la revue Journal of Cell Biology, apporte un nouvel éclairage sur les syndromes myélodysplasiques.
